Showing results (551-560 of 558) with videos related to
Sort By:
Pageof 56
You have reached the last page of results.This site can display upto 558 results.
Journal of the National Cancer Institute|September 2, 2024
Phase III randomized trial comparing neoadjuvant paclitaxel plus platinum with 5-fluorouracil plus platinum in esophageal or gastroesophageal junction squamous cell carcinomaVanita Noronha, Vijay Maruti Patil, Nandini Menon, et al.The Lancet Regional Health. Southeast Asia|August 19, 2024
Uniqueness of lung cancer in Southeast AsiaVanita Noronha, Atul Budukh, Pankaj Chaturvedi, et al.JNCI Cancer Spectrum|July 27, 2024
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancersAnant Ramaswamy, Prabhat Bhargava, Biswajit Dubashi, et al.The New England Journal of Medicine|September 9, 2025
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLCJames Chih-Hsin Yang, Shun Lu, Hidetoshi Hayashi, et al.The New England Journal of Medicine|June 26, 2024
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLCByoung C Cho, Shun Lu, Enriqueta Felip, et al.Journal of Hand and Microsurgery|January 7, 2021
Perspectives and Consensus among International Orthopaedic Surgeons during Initial and Mid-lockdown Phases of Coronavirus DiseaseJ Terrence Jose Jerome, Francisco Mercier, Chaitanya S Mudgal, et al.The Bone & Joint Journal|May 31, 2026
Infection following foot and ankle surgery : a subanalysis of data captured from the UK Foot and Ankle Thromboembolism (FATE) auditJenna Shepherd, Lyndon Mason, Linzy Houchen-Wolloff, et al.The Bone & Joint Journal|October 31, 2024
UK Foot and Ankle Thromboembolism (UK-FATE)Jitendra Mangwani, Linzy Houchen-Wolloff, Karan Malhotra, et al.Pageof 56